HLS Therapeutics Inc.
HLS
Peringkat dalam Saham
#21936
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Harga Saham
$2.94
Terakhir disinkronkan: 2026-10-21
Kapitalisasi Pasar
$90.88M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
-26.92%
Negara
CA
Perdagangan HLS Therapeutics Inc. (HLS)
Kategori
Healthcare
Riwayat harga saham HLS Therapeutics Inc. (HLS)
Harga penutupan tertinggi: $2.76 pada 2026-10-01
Harga penutupan terendah: $0.42 pada 2010-01-01
Harga penutupan terendah: $0.42 pada 2010-01-01
Riwayat harga saham HLS Therapeutics Inc. dari 2010 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | -6.31% |
| 2025 | 36.44% |
| 2024 | -11.68% |
| 2023 | -61.22% |
| 2022 | -36.61% |
| 2021 | -14.29% |
| 2020 | -5.41% |
| 2019 | 23.57% |
| 2018 | 504.45% |
| 2017 | 5.61% |
| 2016 | -1.13% |
| 2015 | 1.31% |
| 2014 | -15.58% |
| 2013 | 6.18% |
| 2012 | 24.32% |
| 2011 | 122.54% |
| 2010 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.67 | 21.65% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $225.66 | 31.77% |
CH
|
|
| $18.43 | -4.03% |
IN
|
